Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics -- Ignore unavailable to you. Want to Upgrade?

To: urslor who wrote (1014)	5/7/2025 2:31:01 PM
From: galt	5 Recommendations Recommended By bobbseytwins2001 CCS648 erippetoe rodneyh07 TripleE3 Read Replies (1) \| Respond to of 1229

Like many here have said, this is acting very much like IMMU and has given many of us the conviction to buy more. I've continued to add, here, and now have almost as much of it as I had IMMU before it exploded to the upside with the sale. The good news is that because of what eventually happened with IMMU, my position in IBRX is small in $ but large in number of shares. Would sure like to hear something from Patrick about this latest snafu. Unfortunately, he surely knows that he faces a large litigation IF his people toyed with the truth. This would be a good time for Avoro to step in. Unfortunately, Patrick owns too many shares for them get what they want, including operational control. Not sure what will get this turned around. Best